Advertisement

Topics

PHARMA DISCOVERY An Elsevier Event Company Profile

20:41 EDT 25th September 2018 | BioPortfolio

Nil

Location

United States of America

Contact

Phone: 203-840-5642
Fax: 203-840-9642
Email: inquiry@pharmadiscoveryevent.com


News Articles [1347 Associated News Articles listed on BioPortfolio]

Winners of the 2018 Elsevier Foundation Green and Sustainable Chemistry Challenge

(Elsevier) Two new chemistry solutions that use guava leaves to combat food spoilage and turn fish bones into phosphate rich fertilizer won the Elsevier Foundation Green and Sustainable Chemistry Chal...

Elsevier/Bayer study findings could cut animal testing

A new analysis of safety reporting data by analytics group Elsevier and Bayer has found that some animal tests are far more predictive of human response than others.

Elsevier launches Mendeley Data

Elsevier, the information analytics business specializing in science and health, has launched Mendeley Data, a new, cloud-based platform designed to help universities and researchers manage, share and...

Why pharma needs to embrace AI to reimagine drug discovery

Ian Churcher, vice president of drug discovery at BenevolentAI, argues that pharma needs to embrace artificial…

Elsevier Launches The Hive for 2017 to Showcase Pharma and Biotech Startup Innovation

Application process for innovation hub now open – with a minimum of eight startups working on cutting-edge science to be selected

BioCity-backed CROs target biotech, mid-sized pharma customers in new discovery alliance

XenoGesis and BioAscent have teamed up to fill "a gap in the market" for integrated drug discovery services aimed at biotech, mid-sized pharma, and academic drug developers, says CEO.

#news #biotech Photosynthesis discovery could help next-gen biotechnologies

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Photosynthesis discovery could help next-gen biotechnologies .Researchers fro...

Elsevier’s decision support tool helps radiologists cut down on diagnostic errors

New research shows that STATdx, Elsevier’s new online diagnostic decision support tool, can reduce diagnostic errors by radiologists by 19 percent.

Drugs and Medications [286 Associated Drugs and Medications listed on BioPortfolio]

Caraderma [A Refreshing Discovery, Inc.]

CaraDerma acne treatment

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [912 Associated PubMed Articles listed on BioPortfolio]

Removal notice to "A "cough induced" pelvic fracture as the first sign of a malignant neoplasm" IJSCR Volume 11 (2015) 75-77.

This article has been removed: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been removed at the request ...

Early Probe and Drug Discovery in Academia: A Minireview.

Drug discovery encompasses processes ranging from target selection and validation to the selection of a development candidate. While comprehensive drug discovery work flows are implemented predominant...

Leveraging Semantic Labels for Multi-level Abstraction in Medical Process Mining and Trace Comparison.

Many medical information systems record data about the executed process instances in the form of an event log. In this paper, we present a framework, able to convert actions in the event log into high...

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System.

The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) is an important source for detecting adverse drug event (ADE) signals. In this article, we propose a three-component mi...

Clinical Trials [1158 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

Companies [2099 Associated Companies listed on BioPortfolio]

PHARMA DISCOVERY An Elsevier Event

Nil

Elsevier MDL

Elsevier MDL is the pioneering leader in discovery informatics. Over 1,000 life science companies supercharge their discovery engines with MDL software solutions to generate fresh ideas and make break...

Elsevier and Elsevier Properties SA

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium(TM), Beilstein and Reaxys databases...

Elsevier Properties and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, Beilstein and Reaxys databases. Tr...

Elsevier Properties SA and Elsevier

Elsevier Properties SA is a center of excellence within Reed Elsevier for the management of intellectual property. Elsevier Properties SA owns the PharmaPendium, and Reaxys databases. Trademarks i...

More Information about "PHARMA DISCOVERY An Elsevier Event" on BioPortfolio

We have published hundreds of PHARMA DISCOVERY An Elsevier Event news stories on BioPortfolio along with dozens of PHARMA DISCOVERY An Elsevier Event Clinical Trials and PubMed Articles about PHARMA DISCOVERY An Elsevier Event for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PHARMA DISCOVERY An Elsevier Event Companies in our database. You can also find out about relevant PHARMA DISCOVERY An Elsevier Event Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record